View in EDS HTML Full Text PDF Full Text

Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis.

Saved in:
Bibliographic Details
Title: Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis.
Authors: Feldman SR; Wake Forest School of Medicine, Winston-Salem, NC, USA., Merola JF; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Pariser DM; Eastern Virginia Medical School, Virginia Clinical Research, Inc, Norfolk, VA, USA., Zhang J; Sun Pharmaceutical Industries Inc., Princeton, NJ, USA., Zhao Y; Sun Pharmaceutical Industries Inc., Princeton, NJ, USA., Mendelsohn AM; Sun Pharmaceutical Industries Inc., Princeton, NJ, USA., Gottlieb AB; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Source: The Journal of dermatological treatment [J Dermatolog Treat] 2022 May; Vol. 33 (3), pp. 1670-1675. Date of Electronic Publication: 2021 Mar 18.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33678106
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Feldman+SR%22">Feldman SR</searchLink>; Wake Forest School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Merola+JF%22">Merola JF</searchLink>; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pariser+DM%22">Pariser DM</searchLink>; Eastern Virginia Medical School, Virginia Clinical Research, Inc, Norfolk, VA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Sun Pharmaceutical Industries Inc., Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+Y%22">Zhao Y</searchLink>; Sun Pharmaceutical Industries Inc., Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Mendelsohn+AM%22">Mendelsohn AM</searchLink>; Sun Pharmaceutical Industries Inc., Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Gottlieb+AB%22">Gottlieb AB</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228918133%22">The Journal of dermatological treatment</searchLink> [J Dermatolog Treat] 2022 May; Vol. 33 (3), pp. 1670-1675. <i>Date of Electronic Publication: </i>2021 Mar 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8918133 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-1753 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209546634%22">09546634 </searchLink><i>NLM ISO Abbreviation: </i>J Dermatolog Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33678106
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/09546634.2021.1898528
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1670
    Titles:
      – TitleFull: Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Feldman SR
      – PersonEntity:
          Name:
            NameFull: Merola JF
      – PersonEntity:
          Name:
            NameFull: Pariser DM
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Zhao Y
      – PersonEntity:
          Name:
            NameFull: Mendelsohn AM
      – PersonEntity:
          Name:
            NameFull: Gottlieb AB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2022 May
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1471-1753
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The Journal of dermatological treatment
              Type: main
ResultId 1